BLACKSBURG, Va., Sept. 15 -- Virginia Polytechnic Institute and State University issued the following news release:
Multiparametric flow cytometry - a test that is widely accessible, cost-effective, and timely - can find one cancerous cell hidden among thousands of healthy cells following treatment for acute myeloid leukemia.
Identifying those cells helps doctors monitor disease progression, predict relapse risk, and guide treatment. One way to improve care for the estimated22,720people in the U.S. diagnosed annually with the rare, aggressive blood cancer is to improve the sensitivity and accuracy of testing.
But a research team led by Virginia Tech scientists from the Fralin Biomedical Research Institute's Cancer Research Center in Wash...